AstraZeneca divests Losec (omeprazole) and associated brands rights to Cheplapharm Arzneimittel GmbH
Posted on03 Oct 2019
TagsAcimax, Antra, AstraZeneca, Cheplapharm Arzneimittel GmbH, disinvestment in pharma business, Losec, Mepral, Mopral, Omepral, Zoltum
Comments0
AstraZeneca has agreed to sell the global commercial rights, excluding China, Japan, the US and Mexico, for Losec (omeprazole) and associated brands... Read More